Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bernard

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Haematologica|January 16, 2016
Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient ProgramAurore Perrot, Hélène Monjanel, Réda Bouabdallah, et al.
BMC Family Practice|August 5, 2017
Prevalence of anal symptoms in general practice: a prospective studyGéraldine Tournu, Laurent Abramowitz, Camille Couffignal, et al.
BMC Family Practice|January 19, 2019
Correction to: Prevalence of anal symptoms in general practice: a prospective studyGéraldine Tournu, Laurent Abramowitz, Camille Couffignal, et al.
Haematologica|August 30, 2008
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL studyMathilde Hunault-Berger, Patrice Chevallier, Martine Delain, et al.
Haematologica|June 14, 2005
Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS studyMarc Bernard, Guillaume Cartron, Petronella Rachieru, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang studyEric Deconinck, Mathilde Hunault, Noël Milpied, et al.
Blood|August 9, 2003
Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trialChristine le Maignan, Bernard Desablens, Vincent Delwail, et al.
Blood|January 24, 2012
Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL studyPatrice Chevallier, Nelly Robillard, Aude Charbonnier, et al.
British Journal of Haematology|December 8, 2010
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Marie Robin, Reza Tabrizi, Mohamad Mohty, et al.
Medicine|March 18, 2008
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patientsBenjamin Terrier, Arnaud Jaccard, Jean-Luc Harousseau, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Haematologica|January 16, 2016
Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient ProgramAurore Perrot, Hélène Monjanel, Réda Bouabdallah, et al.
BMC Family Practice|August 5, 2017
Prevalence of anal symptoms in general practice: a prospective studyGéraldine Tournu, Laurent Abramowitz, Camille Couffignal, et al.
BMC Family Practice|January 19, 2019
Correction to: Prevalence of anal symptoms in general practice: a prospective studyGéraldine Tournu, Laurent Abramowitz, Camille Couffignal, et al.
Haematologica|August 30, 2008
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL studyMathilde Hunault-Berger, Patrice Chevallier, Martine Delain, et al.
Haematologica|June 14, 2005
Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS studyMarc Bernard, Guillaume Cartron, Petronella Rachieru, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang studyEric Deconinck, Mathilde Hunault, Noël Milpied, et al.
Blood|August 9, 2003
Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trialChristine le Maignan, Bernard Desablens, Vincent Delwail, et al.
Blood|January 24, 2012
Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL studyPatrice Chevallier, Nelly Robillard, Aude Charbonnier, et al.
British Journal of Haematology|December 8, 2010
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Marie Robin, Reza Tabrizi, Mohamad Mohty, et al.
Medicine|March 18, 2008
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patientsBenjamin Terrier, Arnaud Jaccard, Jean-Luc Harousseau, et al.
Pageof 6